InsiderSignalSign in

← Insider buys

Forest Baskett has bought stock on 37 days since Jan 2016

10% owner at Korro Bio, Inc., and 25 other companies

SEC CIK 0001277631 · Filings on SEC.gov ↗

$235.1MBought

$153.6MSold

Mar 12Last buy

Forest Baskett's record

3 months after each buy, from the first price a copier could get.

−3.5%Average

−6.6 ptsVs S&P 500

2 of 6Higher

6 buys since 2016 with 3 months of prices.

Companies

Every filing

55 filings since Jan 2016, newest first

Korro Bio, Inc.

10% owner

$2.3M+19.0%Mar 12

Spyglass Pharma, Inc.

10% owner

$15.0M+15.0%Feb 11

Mbx Biosciences, Inc.

10% owner

$8.0M+16.0%Sep 17

Korro Bio, Inc.

10% owner

$1.0M+2.0%Apr 24

Savara Inc

10% owner

$1.0M+1.0%Jul 19

Arcellx, Inc.

10% owner

Genocea Biosciences, Inc.

10% owner

$751K−100.0%May 26

Trevi Therapeutics, Inc.

10% owner

$5.0M+34.0%Apr 13

Robinhood Markets, Inc.

Director

Metacrine, Inc.

10% owner

$494K−16.0%Dec 27

Ardelyx, Inc.

10% owner

$3.6M−21.0%Dec 27

Marker Therapeutics, Inc.

10% owner

$10.0M+114.0%Mar 18

Regulus Therapeutics Inc.

10% owner

$2.7M+214.0%Dec 7

Cloudflare, Inc.

10% owner

$1.3M−1.0%Nov 13

Cloudflare, Inc.

10% owner

$17.6M−14.0%Aug 21

Cloudflare, Inc.

10% owner

$16.2M−11.0%Aug 18

Cloudflare, Inc.

10% owner

$28.4M−17.0%Aug 13

Cloudflare, Inc.

10% owner

$3.4M−2.0%Aug 10

Akouos, Inc.

10% owner

$10.0M+16.0%Jul 1

Ardelyx, Inc.

10% owner

$719K−1.0%Jun 12

Cloudflare, Inc.

10% owner

$9.6M−8.0%May 21

Mersana Therapeutics, Inc.

10% owner

Adaptimmune Therapeutics Plc

10% owner

$5.0M+8.0%Jan 28

Trevi Therapeutics, Inc.

10% owner

$25.0M+129.0%May 13

Regulus Therapeutics Inc.

10% owner

$1.2M+124.0%May 9

Aveo Pharmaceuticals Inc

10% owner

$5.0M+21.0%Apr 8

Aveo Pharmaceuticals Inc

10% owner

$774K+2.0%Dec 21

Aveo Pharmaceuticals Inc

10% owner

Aveo Pharmaceuticals Inc

10% owner

$338K+1.0%Dec 10

Aveo Pharmaceuticals Inc

10% owner

Aveo Pharmaceuticals Inc

10% owner

$336K+1.0%Nov 21

Aveo Pharmaceuticals Inc

10% owner

$2.2M+6.0%Nov 19

Adaptimmune Therapeutics Plc

10% owner

$25.0M+19.0%Sep 10

Aveo Pharmaceuticals Inc

10% owner

$1.5M+4.0%Aug 22

Aveo Pharmaceuticals Inc

10% owner

$492K+1.0%Jul 20

Aveo Pharmaceuticals Inc

10% owner

Surface Oncology, Inc.

10% owner

$2.0M+4.0%Apr 23

Aveo Pharmaceuticals Inc

10% owner

$2.1M+6.0%Apr 10

Adaptimmune Therapeutics Plc

10% owner

$12.6M+9.0%Mar 28

Tracon Pharmaceuticals, Inc.

10% owner

$1.9M+26.0%Mar 27

Adaptimmune Therapeutics Plc

10% owner

$2.4M+2.0%Mar 23

Tesaro, Inc.

10% owner

$8.4M+1.0%Mar 6

Arca Biopharma, Inc.

10% owner

$731K−100.0%Feb 27

Appian Corp

10% owner

$11.1M−100.0%Nov 27

Appian Corp

10% owner

$55.0M−100.0%Nov 21

Rhythm Pharmaceuticals, Inc.

10% owner

$9.3M+13.0%Oct 10

Mersana Therapeutics, Inc.

10% owner

$15.0M+14.0%Jul 6

Aveo Pharmaceuticals Inc

10% owner

$3.0M+58.0%Mar 29

Adaptimmune Therapeutics Plc

10% owner

$9.0M+22.0%Mar 28

Tableau Software Inc

Director

$495K−100.0%Dec 6

About Forest Baskett

Forest Baskett is a General Partner at New Enterprise Associates (NEA), a prominent venture capital firm, where he has focused on investments in technology, software, healthcare devices, and related sectors since joining as a Venture Partner in 1999.( As a 10% owner of SpyGlass Pharma, Inc. (SGP), Baskett is listed among insiders involved in recent equity transactions around the company's initial public offering on February 9, 2026, including automatic conversions of preferred stock to common stock and purchases through NEA funds such as NEA 17 and NEA 16, resulting in holdings exceeding 6 million shares indirectly.(

Baskett's distinguished career includes serving as Chief Technology Officer and Senior Vice President at Graphics Properties Holdings, Inc., and Silicon Graphics Inc., founding the Western Research Laboratory of Digital Equipment Corporation (1982-1986), and professorship in Computer Science and Electrical Engineering at Stanford University (1971-1982).( He holds a Ph.D. in Computer Science from the University of Texas at Austin and a B.A. in Mathematics from Rice University, and is a member of the National Academy of Engineering.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.